Short-term changes of visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration

摘要

Visual hallucinations are frequently reported by patients with severe forms of age-related macular degeneration (AMD). The phenomena, which are also known by the eponym Charles-Bonnet syndrome, have also been described in AMD patients after treatment including macular photocoagulation, photodynamic therapy, limited macular translocation,and intravitreal Bevacizumab (Avastin) injection. Our study aims to describe the occurrence and course of visual hallucinations after intravitreal Ranibizumab (Lucentis) injection.